After Years of Legal Hardball, Merck Settles Vioxx Case for $4.85 Billion
The drug maker agreed to pay $4.85 billion to settle lawsuits from individuals who say its painkiller Vioxx led to heart attacks and strokes. Predictions put the settlement costs at $25 billion when Vioxx was taken off the market in September 2004.

A new report from the World Cancer Research Fund and the American Institute for Cancer Research is the largest study ever to explore the connection between lifestyle and cancer, and represents the work of nine independent research teams that evaluated over 7000 existing studies over five years.
The Centers for Disease Control and Prevention recently reported that 25 to 30 percent of the U.S. population carries the staph bacteria MRSA, which was for responsible for more than 94,000 life-threatening infections and 19,000 deaths in 2005.